NATURAL ALTERNATIVES INTERNATIONAL INC
Business
Natural Alternatives International (NAI) is a formulator, manufacturer and marketer of nutritional supplements, with operations in California and Switzerland. The company provides private-label contract manufacturing services for vitamins, minerals, herbs and nutritional supplements, along with comprehensive services including formulation, clinical studies, regulatory support and packaging design. NAI also commercializes a patent estate in beta-alanine through direct raw material sales and licensing under the CarnoSyn®, SR CarnoSyn® and TriBsyn™ trademarks. The company serves customers globally through direct sales, e-commerce and retail channels, with principal markets in the U.S., Europe and Asia.
Summary from 10-K filed 2025-09-23
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Net sales | 130 | 114 | 154 | 171 | 179 | |
| Cost of goods sold | 121 | 107 | 136 | 140 | 148 | |
| Gross profit | 9 | 7 | 18 | 31 | 30 | |
| Other selling, general and administrative expenses | 17 | 15 | 15 | 17 | 17 | |
| Settlement of legal proceeding and associated expense | 1 | 0 | — | — | — | |
| Loss from operations | −9 | −9 | 5 | 14 | 14 | |
| Interest income | 168,000 | 176,000 | 33,000 | 0 | 1,000 | |
| Interest expense | −915,000 | −361,000 | −451,000 | −83,000 | −118,000 | |
| Foreign exchange loss | −1 | −652,000 | −658,000 | 118,000 | −1 | |
| Other, net | 7,000 | −93,000 | −82,000 | −55,000 | −21,000 | |
| Total other expense | −2 | −930,000 | −1 | −20,000 | −2 | |
| Loss before income taxes | −11 | −9 | 4 | 14 | 12 | |
| Provision (benefit) for income taxes | 3 | −2 | 1 | 3 | 1 | |
| Net loss | −14 | −7 | 3 | 11 | 11 | |
| Change in minimum pension liability, net of tax | 50,000 | 102,000 | 64,000 | 94,000 | 350,000 | |
| Unrealized loss resulting from change in fair value of derivative instruments, net of tax | −1 | −41,000 | −2 | 2 | 272,000 | |
| Comprehensive loss | −15 | −7 | 740,000 | 13 | 11 | |
| Basic (in dollars per share) | −2.28 | −1.23 | 0.43 | 1.75 | 1.71 | |
| Diluted (in dollars per share) | −2.28 | −1.23 | 0.43 | 1.74 | 1.69 | |
| Basic (in shares) | 6 | 6 | 6 | 6 | 6 | |
| Diluted (in shares) | 6 | 6 | 6 | 6 | 6 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 12 | 12 | 14 | 22 | 32 | |
| Accounts receivable less allowance for credit losses of $0 at June 30, 2025 and June 30, 2024 | 15 | 17 | 7 | 17 | 18 | |
| Inventories, net | 25 | 24 | 30 | 32 | 27 | |
| Income tax receivable | 276,000 | 0 | 305,000 | 67,000 | 1 | |
| Forward contracts | 368,000 | 492,000 | 390,000 | 3 | 0 | |
| Prepaids and other current assets | 7 | 8 | 6 | 2 | 2 | |
| Total current assets | 59 | 62 | 57 | 77 | 80 | |
| Property and equipment, net | 51 | 52 | 54 | 45 | 22 | |
| Operating lease right-of-use assets | 41 | 44 | 20 | 22 | 16 | |
| Deferred tax asset, net noncurrent | 0 | 3 | 355,000 | 0 | 214,000 | |
| Other noncurrent assets, net | 719,000 | 2 | 3 | 3 | 2 | |
| Total assets | 152 | 162 | 134 | 146 | 120 | |
| Accounts payable | 15 | 13 | 8 | 16 | 12 | |
| Accrued liabilities | 3 | 3 | 2 | 3 | 2 | |
| Accrued compensation and employee benefits | 2 | 2 | 2 | 4 | 5 | |
| Customer deposits | 1 | 302,000 | 317,000 | 140,000 | 2 | |
| Short-term liability operating leases | 2 | 1 | 2 | — | — | |
| Forward contracts | 2 | 91,000 | 0 | 634,000 | 814,000 | |
| Income taxes payable | 411,000 | 505,000 | 374,000 | 174,000 | 619,000 | |
| Mortgage note payable, current portion | 305,000 | 296,000 | 312,000 | 302,000 | 0 | |
| Line of credit current | 2 | 3 | 0 | — | — | |
| Total current liabilities | 29 | 23 | 16 | 24 | 22 | |
| Long-term liability operating leases | 46 | 46 | 19 | 21 | 16 | |
| Long-term pension liability | 111,000 | 141,000 | 339,000 | 344,000 | 391,000 | |
| Mortgage note payable, net of current portion | 9 | 9 | 9 | 9 | 0 | |
| Income taxes payable, noncurrent | 0 | 740,000 | 987,000 | 1 | 1 | |
| Total liabilities | 84 | 80 | 45 | 57 | 40 | |
| Commitments and contingencies (Notes D, F, H, J and M) | — | — | — | — | — | |
| Preferred stock; $.01 par value; 500,000 shares authorized; none issued or outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock; $.01 par value; 20,000,000 shares authorized at June 30, 2025 and June 30, 2024, issued and outstanding (net of treasury shares) 6,178,213 at June 30, 2025 and 6,200,185 at June 30, 2024 | 93,000 | 93,000 | 91,000 | 89,000 | 88,000 | |
| Additional paid-in capital | 34 | 33 | 31 | 30 | 29 | |
| Retained earnings | 59 | 73 | 80 | 78 | 67 | |
| Treasury stock, at cost, 3,326,693 shares at June 30, 2025 and 3,280,721 at June 30, 2024 | −23 | −23 | −23 | −21 | — | |
| Accumulated other comprehensive loss | −1 | −22,000 | −83,000 | 2 | −561,000 | |
| Total stockholders equity | 68 | 83 | 89 | 89 | 80 | |
| Total liabilities and stockholders equity | 152 | 162 | 134 | 146 | 120 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 5 | 5 | 4 | 4 | 4 | |
| Deferred income taxes | 4 | −3 | −974,000 | 751,000 | −214,000 | |
| Non-cash lease expenses | 7 | 6 | 3 | 3 | 3 | |
| Non-cash compensation | 977,000 | 1 | 1 | 968,000 | 1 | |
| Pension expense, net of contributions | 81,000 | 46,000 | 81,000 | 83,000 | 163,000 | |
| Loss on disposal of assets | 49,000 | 0 | — | — | — | |
| Accounts receivable | 2 | −10 | 12 | 644,000 | −813,000 | |
| Inventories | −622,000 | 5 | 3 | −5 | 966,000 | |
| Prepaids and other assets | 2 | −2 | −4 | 75,000 | −358,000 | |
| Accounts payable and accrued liabilities | 3 | 5 | −9 | 3 | 2 | |
| Operating lease liabilities | −4 | −3 | −2 | −3 | −3 | |
| Forward contracts | 176,000 | 372,000 | 863,000 | −2 | 1 | |
| Income taxes | −1 | 189,000 | −169,000 | 451,000 | −737,000 | |
| Accrued compensation and employee benefits | 36,000 | −273,000 | −1 | −911,000 | 2 | |
| Net cash provided by (used in) operating activities | 6 | −1 | 7 | 12 | 21 | |
| Purchases of property and equipment | −4 | −3 | −14 | −26 | −5 | |
| Net cash used in investing activities | −4 | −3 | −13 | −26 | −5 | |
| (Payments) Borrowings on line of credit | −2 | 3 | — | 0 | −10 | |
| Repurchase of common stock | −178,000 | −221,000 | −2 | −6 | −4 | |
| Payments on long-term debt | −296,000 | −288,000 | −278,000 | −205,000 | 0 | |
| Net cash (used in) provided by financing activities | −2 | 3 | −2 | 4 | −14 | |
| Net increase (decrease) in cash and cash equivalents | 344,000 | −2 | −8 | −10 | 2 | |
| Income taxes | 323,000 | 463,000 | 2 | 3 | 3 | |
| Interest | 814,000 | 285,000 | 802,000 | 206,000 | 131,000 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is NATURAL ALTERNATIVES INTERNATIONAL INC's CIK number?
NATURAL ALTERNATIVES INTERNATIONAL INC's SEC CIK number is 0000787253 (787253). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find NATURAL ALTERNATIVES INTERNATIONAL INC's SEC filings?
All of NATURAL ALTERNATIVES INTERNATIONAL INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.